Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin) In Canada Read more
Samumed And United Therapeutics Announce North American License Agreement For Samumed’s IPF Drug Candidate Read more
CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes Read more
Antibiotic Class Emerges through Digestive Enzyme, find out more at 3rd Annual Superbugs and Superdrugs USA Conference Read more